130 related articles for article (PubMed ID: 8934574)
1. High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters.
Himes SR; Coles LS; Reeves R; Shannon MF
Immunity; 1996 Nov; 5(5):479-89. PubMed ID: 8934574
[TBL] [Abstract][Full Text] [Related]
2. RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter.
Lai JH; Horvath G; Subleski J; Bruder J; Ghosh P; Tan TH
Mol Cell Biol; 1995 Aug; 15(8):4260-71. PubMed ID: 7623820
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor of activated T cells contributes to the function of the CD28 response region of the granulocyte macrophage-colony stimulating factor promoter.
Shang C; Attema J; Cakouros D; Cockerill PN; Shannon MF
Int Immunol; 1999 Dec; 11(12):1945-56. PubMed ID: 10590260
[TBL] [Abstract][Full Text] [Related]
4. Regulation of the interleukin-2 CD28-responsive element by NF-ATp and various NF-kappaB/Rel transcription factors.
Maggirwar SB; Harhaj EW; Sun SC
Mol Cell Biol; 1997 May; 17(5):2605-14. PubMed ID: 9111330
[TBL] [Abstract][Full Text] [Related]
5. Temporal and subunit-specific modulations of the Rel/NF-kappaB transcription factors through CD28 costimulation.
Kahn-Perlès B; Lipcey C; Lécine P; Olive D; Imbert J
J Biol Chem; 1997 Aug; 272(35):21774-83. PubMed ID: 9268307
[TBL] [Abstract][Full Text] [Related]
6. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation.
Himes SR; Reeves R; Attema J; Nissen M; Li Y; Shannon MF
J Immunol; 2000 Mar; 164(6):3157-68. PubMed ID: 10706706
[TBL] [Abstract][Full Text] [Related]
7. Functional disparity of distinct CD28 response elements toward mitogenic responses.
Civil A; Rensink I; Aarden LA; Verweij CL
J Biol Chem; 1999 Nov; 274(48):34369-74. PubMed ID: 10567414
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter.
González E; Punzón C; González M; Fresno M
J Immunol; 2001 Apr; 166(7):4560-9. PubMed ID: 11254713
[TBL] [Abstract][Full Text] [Related]
9. Coordinate transactivation of the interleukin-2 CD28 response element by c-Rel and ATF-1/CREB2.
Butscher WG; Powers C; Olive M; Vinson C; Gardner K
J Biol Chem; 1998 Jan; 273(1):552-60. PubMed ID: 9417115
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Rel, Fos, and Jun proteins in binding activity to the IL-2 promoter CD28 response element/AP-1 sequence in human T cells.
McGuire KL; Iacobelli M
J Immunol; 1997 Aug; 159(3):1319-27. PubMed ID: 9233628
[TBL] [Abstract][Full Text] [Related]
11. NF-kappaB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity.
Sánchez-Valdepeñas C; Martín AG; Ramakrishnan P; Wallach D; Fresno M
J Immunol; 2006 Apr; 176(8):4666-74. PubMed ID: 16585559
[TBL] [Abstract][Full Text] [Related]
12. Depletion of c-Rel from cytokine gene promoters is required for chromatin reassembly and termination of gene responses to T cell activation.
Poke FS; Upcher WR; Sprod OR; Young A; Brettingham-Moore KH; Holloway AF
PLoS One; 2012; 7(7):e41734. PubMed ID: 22860011
[TBL] [Abstract][Full Text] [Related]
13. Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB.
Kalli K; Huntoon C; Bell M; McKean DJ
Mol Cell Biol; 1998 Jun; 18(6):3140-8. PubMed ID: 9584155
[TBL] [Abstract][Full Text] [Related]
14. GM-CSF and IL-2 share common control mechanisms in response to costimulatory signals in T cells.
Shannon MF; Himes SR; Coles LS
J Leukoc Biol; 1995 May; 57(5):767-73. PubMed ID: 7759956
[TBL] [Abstract][Full Text] [Related]
15. TCR/CD28-stimulated actin dynamics are required for NFAT1-mediated transcription of c-rel leading to CD28 response element activation.
Nolz JC; Fernandez-Zapico ME; Billadeau DD
J Immunol; 2007 Jul; 179(2):1104-12. PubMed ID: 17617603
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms underlying differential contribution of CD28 versus non-CD28 costimulatory molecules to IL-2 promoter activation.
Zhou XY; Yashiro-Ohtani Y; Nakahira M; Park WR; Abe R; Hamaoka T; Naramura M; Gu H; Fujiwara H
J Immunol; 2002 Apr; 168(8):3847-54. PubMed ID: 11937538
[TBL] [Abstract][Full Text] [Related]
17. Rel-deficient T cells exhibit defects in production of interleukin 3 and granulocyte-macrophage colony-stimulating factor.
Gerondakis S; Strasser A; Metcalf D; Grigoriadis G; Scheerlinck JY; Grumont RJ
Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3405-9. PubMed ID: 8622948
[TBL] [Abstract][Full Text] [Related]
18. Identification of a CD28 response element in the CD40 ligand promoter.
Parra E; Mustelin T; Dohlsten M; Mercola D
J Immunol; 2001 Feb; 166(4):2437-43. PubMed ID: 11160303
[TBL] [Abstract][Full Text] [Related]
19. c-Rel is required for chromatin remodeling across the IL-2 gene promoter.
Rao S; Gerondakis S; Woltring D; Shannon MF
J Immunol; 2003 Apr; 170(7):3724-31. PubMed ID: 12646638
[TBL] [Abstract][Full Text] [Related]
20. CD28 mediates transcriptional upregulation of the interleukin-2 (IL-2) promoter through a composite element containing the CD28RE and NF-IL-2B AP-1 sites.
Shapiro VS; Truitt KE; Imboden JB; Weiss A
Mol Cell Biol; 1997 Jul; 17(7):4051-8. PubMed ID: 9199340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
